Literature DB >> 3920533

Construction of chimaeric processed immunoglobulin genes containing mouse variable and human constant region sequences.

S Takeda, T Naito, K Hama, T Noma, T Honjo.   

Abstract

The specificity of monoclonal antibodies provides a powerful diagnostic and therapeutic tool in investigating human neoplasia. Radiological scanning and immunotherapy with mouse tumour-specific monoclonal antibodies have been applied to patients with some success, but a major problem is the neutralization of the mouse antibody induced by repeated administration of heterologous antibodies. To avoid or reduce such immune reactions, chimaeric immunoglobulins consisting of mouse variable (V) and human constant (C) regions can be synthesized. We have constructed a recombinant retrovirus DNA carrying genomic heavy-chain (H) variable-diversity joining (VH-D-JH) and C gamma 1 genes from different species and show here that the chimaeric intervening sequences are spliced out precisely. This procedure provides a useful method to construct the chimaeric mouse-human immunoglobulin gene to be expressed in Escherichia coli, yeast and animal cells. Unexpectedly, a hidden splice donor site in the 5'-flanking region of a human VH gene is used in place of the donor site of the leader sequence exon, resulting in the formation of the V region without the leader sequence.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920533     DOI: 10.1038/314452a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  8 in total

1.  Design and synthesis of a Magainin2 fusion protein gene suitable for a mammalian expression system.

Authors:  Baoliang Fan; Ning Li
Journal:  Transgenic Res       Date:  2008-10-16       Impact factor: 2.788

2.  Homologous recombination in hybridoma cells: heavy chain chimeric antibody produced by gene targeting.

Authors:  H P Fell; S Yarnold; I Hellström; K E Hellström; K R Folger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 3.  Monoclonal antibodies in clinical medicine.

Authors:  H M Dick
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-21

Review 4.  Expression of recombinant immunoglobulin genes to produce novel molecules with specific functions.

Authors:  C A Gritzmacher
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

5.  Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A.

Authors:  L K Sun; P Curtis; E Rakowicz-Szulczynska; J Ghrayeb; N Chang; S L Morrison; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

Review 6.  Novel immunologic and biologic therapies for breast cancer.

Authors:  J C Gutheil
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

7.  Identification of human antibody fragment clones specific for tetanus toxoid in a bacteriophage lambda immunoexpression library.

Authors:  R L Mullinax; E A Gross; J R Amberg; B N Hay; H H Hogrefe; M M Kubitz; A Greener; M Alting-Mees; D Ardourel; J M Short
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

8.  Tolerance to rat monoclonal antibodies. Implications for serotherapy.

Authors:  R J Benjamin; S P Cobbold; M R Clark; H Waldmann
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.